NuPulse Voyage
Chronic Heart Failure (Bridge-to-Transplant / Destination Therapy)
Key Facts
About NuPulseCV
NuPulseCV is a clinical-stage medical device company pioneering a novel approach to mechanical circulatory support for chronic heart failure patients. Its flagship product, the NuPulse Voyage, is a minimally invasive, portable system that utilizes counterpulsation technology, aiming to serve as a bridge-to-transplant or destination therapy while enabling patient mobility and discharge. Founded in 2015 and based in Durham, NC, the company has completed an 81-patient early feasibility study with promising results and is now advancing toward a pivotal trial. NuPulseCV seeks to address a significant gap in long-term, ambulatory cardiac support for a large and growing patient population.
View full company profile